$PCRX
Pacira Biosciences Inc Stock $pcrx

2011 Q2 Form 10-Q Financial Statement

Concept	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.20M
YoY Change
Cash & Equivalents	$27.45M
Short-Term Investments	$19.80M
Other Short-Term Assets	$3.500M
YoY Change
Inventory	$1.900M
Prepaid Expenses
Receivables	$1.100M
Other Receivables	$0.00
Total Short-Term Assets	$53.60M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$24.60M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.100M
YoY Change
Total Long-Term Assets	$33.50M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$53.60M
Total Long-Term Assets	$33.50M
Total Assets	$87.10M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.100M
YoY Change
Accrued Expenses	$3.600M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$6.300M
YoY Change
Total Short-Term Liabilities	$17.50M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$22.60M
YoY Change
Other Long-Term Liabilities	$24.10M
YoY Change
Total Long-Term Liabilities	$46.70M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.50M
Total Long-Term Liabilities	$46.70M
Total Liabilities	$64.20M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000K
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.90M
YoY Change
Total Liabilities & Shareholders Equity	$87.10M
YoY Change

Concept	2011 Q2
OPERATING ACTIVITIES
Net Income	-$8.763M
YoY Change	28.87%
Depreciation, Depletion And Amortization	$400.0K
YoY Change	-60.78%
Cash From Operating Activities	-$10.92M
YoY Change	28.02%
INVESTING ACTIVITIES
Capital Expenditures	-$1.210M
YoY Change	-19.33%
Acquisitions
YoY Change
Other Investing Activities	-$19.76M
YoY Change
Cash From Investing Activities	-$20.96M
YoY Change	1297.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-10.92M
Cash From Investing Activities	-20.96M
Cash From Financing Activities	0.000
Net Change In Cash	-31.88M
YoY Change	-1871.11%
FREE CASH FLOW
Cash From Operating Activities	-$10.92M
Capital Expenditures	-$1.210M
Free Cash Flow	-$9.710M
YoY Change	38.12%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2000